Loading clinical trials...
Loading clinical trials...
Fecal Microbiota Transplantation to Eradicate Antibiotic-resistance Bacteria From the Gastrointestinal Tract of Patients at High Risk of Infection and/or to Cut Off the Spread of Bacteria With Dangerous Mechanisms of Antibiotic Resistance
Conditions
Interventions
Fecal Microbiota Transplantation
Locations
5
Poland
Uniwersyteckie Centrum Kliniczne, Klinika Gastroenterologii i Hepatologii
Gdansk, Poland
Uniwersyteckie Centrum Kliniczne, Klinika Hematologii i Transplantologii
Gdansk, Poland
Uniwersyteckie Centrum Kliniczne, Klinika Pediatrii, Hematologii i Onkologii
Gdansk, Poland
WOJEWÓDZKI SZPITAL ZESPOLONY W KIELCACH, Klinika Chorób Zakaźnych
Kielce, Poland
WIM-PIB: Klinika Chorób Infekcyjnych i Alergologii, Klinika Gastroenterologii i Chorób Wewnętrznych
Warsaw, Poland
Start Date
October 27, 2023
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2025
Last Updated
December 5, 2023
NCT07052604
NCT07226557
NCT00484055
Lead Sponsor
Human Biome Institute S.A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions